Press Release

22.02.2018

Four communications on SCCA and SCCA-IgM at the 2018 AISF meeting

The AISF annual meeting is taking place today and tomorrow in Rome.
This year, four presentations are dedicated to SCCA and SCCA-IgM: one oral communication is on the role of SCCA-IgM as a biomarker of non-alcoholic steato-hepatitis (NASH) development and progression; one poster shows how free serum SCCA is a promising prognostic marker in patients with perihilar cholangiocarcinoma; another poster provides insights into the supportive role of SCCA in cholangiocarcinoma initiation; and one poster focuses on the correlation between SCCA-IgM levels and survival in cirrhotic patients.

All the abstracts of the meeting can be downloaded HERE.